Cases 1 - 5 of 5
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Abraxis BioScience, LLC et al v. HBT Labs, Inc.
as 1:2018cv02019
Plaintiff:
Celgene Corporation and Abraxis BioScience, LLC
Defendant:
HBT Labs, Inc.
Cause Of Action: 35 U.S.C. § 271
ABRAXIS BIOSCIENCE, LLC et al v. HBT LABS, INC.
as 2:2018cv17304
Plaintiff:
CELGENE CORPORATION and ABRAXIS BIOSCIENCE, LLC
Defendant:
HBT LABS, INC.
Cause Of Action: 15 U.S.C. § 1126
Amgen Inc. v. Emcure Pharmaceuticals Ltd. et al
as 1:2018cv01393
Defendant:
Emcure Pharmaceuticals Ltd., Heritage Pharma Labs Inc. and Heritage Pharmaceuticals Inc.
Plaintiff:
Amgen Inc.
Cause Of Action: 35 U.S.C. § 271
BRISTOL-MYERS SQUIBB COMPANY v. EMCURE PHARMACEUTICALS LIMITED et al
as 3:2017cv06832
Plaintiff:
BRISTOL-MYERS SQUIBB COMPANY
Defendant:
EMCURE PHARMACEUTICALS LIMITED, HERITAGE PHARMA LABS INC. and HERITAGE PHARMACEUTICALS INC.
Cause Of Action: 15 U.S.C. § 1126
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
